Recruiting
Phase 1

Sponsor:

Richard Stone, MD

Code:

NCT06313437

Conditions

Acute Myeloid Leukemia

AML, Adult

AML With Gene Mutations

AML

Leukemia

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Revumenib

Midostaurin

Cytarabine

Daunorubicin

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-06-15. This information was provided to ClinicalTrials.gov by Richard Stone, MD on 2025-03-27.